NCT03126578View on ClinicalTrials.gov

Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 and Midazolam

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2017

Primary Completion Date

October 20, 2017

Study Completion Date

October 20, 2017

Conditions
Drug Interaction Potentiation
Interventions
DRUG

LEO 32731

LEO 32731 is being developed by LEO Pharma.

DRUG

Midazolam

Benzodiazepine

Trial Locations (1)

89231

Nuvisan GmbH, Neu-Ulm

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY